PCR93 Effect of Physicians’ Prescribing Choices of First- or Second-Line Tumor Necrosis Factor Inhibitor Biologics Versus Non-Tumor Necrosis Factor Inhibitor Biologic Therapies on Psoriatic Arthritis Patient-Reported Outcomes
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1871
https://www.valueinhealthjournal.com/article/S1098-3015(23)01971-X/fulltext
Title :
PCR93 Effect of Physicians’ Prescribing Choices of First- or Second-Line Tumor Necrosis Factor Inhibitor Biologics Versus Non-Tumor Necrosis Factor Inhibitor Biologic Therapies on Psoriatic Arthritis Patient-Reported Outcomes
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01971-X&doi=10.1016/j.jval.2023.03.1871
First page :
Section Title :
Open access? :
No
Section Order :
11189